Recognized each November, National Native American Heritage Month commemorates the culture, traditions and achievements of Indigenous People. #NativeAmericanHeritageMonth
关于我们
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines *in collaboration with AbbVie
- 网站
-
https://www.neurocrine.com
Neurocrine Biosciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- San Diego，California
- 类型
- 上市公司
- 创立
- 1992
- 领域
- Movement Disorders、CNS、Neurology和Endocrinology
地点
Neurocrine Biosciences员工
-
Matt Crawford, MBA
Regional Specialty Manager - Long Term Care at Neurocrine Biosciences
-
Hector Ortega
Award-Winning Key Account Manager | I Help Biopharma Engage High Value Customers | C-Suite, HCPs, IDNs, KOLs | Increase Access | Improve Health…
-
Lori Hodsoll, PACS
Regional Patient Access Manager
-
Joe Rudman
动态
-
We were thrilled to host students from?Charles R. Drew University of Medicine and Science's Biomedical Sciences Enrichment Program at our headquarters in San Diego! During the visit, the students met with a panel of employees, learned about our R&D labs and explored our summer internship program. Thank you, CDU students!?
-
-
We are proud to recognize Nurse Practitioner Week, which honors NPs for the fundamental and versatile roles they play on patient care teams. All Advanced Practice Providers, like NPs, can help improve the recognition, diagnosis and management of tardive dyskinesia by making screening a part of their clinical routine for all patients on dopamine receptor blocking agents. Read more about the importance of routine screening for TD in this article, sponsored by Neurocrine and published in the?Psychiatric Times https://lnkd.in/g_T4nD7w
-
-
Today we presented subgroup analyses and data from the KINECT?-HD study evaluating the emotional health and psychiatric stability in patients with chorea associated with Huntington’s disease.?https://lnkd.in/gGm_QzWk Huntington Study Group #HSG2024
-
-
As our newly appointed CEO, Kyle W. Gano, Ph.D., shared his enthusiasm for Neurocrine’s future on our Q3 2024 #EarningsCall. ICYMI, you can read the transcript here: https://lnkd.in/g6wZX4bQ $NBIX
-
-
Today we held our Q3 2024 #EarningsCall. Read our financial results here:?https://lnkd.in/g-eurFXp $NBIX
-
-
We are closing enrollment on our 2025-2027?University of Southern California - Neurocrine Biosciences Postdoctoral Fellowship Program on November 30th. Apply today for one of our fellowship opportunities on our Medical and Clinical teams. Upon completion of the program, fellows will be more prepared for a career in the pharmaceutical industry within their respective functional areas. If you were unable to attend one of our informational webinars, we are hosting a third webinar on Wednesday, October 23rd from 5:00PM – 6:00PM PT/ 8:00PM – 9:00PM ET. Register today: https://lnkd.in/gYXtXkrr
-
Today marks the beginning of a new chapter for Neurocrine as?Kyle W. Gano steps into his role as CEO. Under Kyle’s leadership, we will continue working tirelessly to develop life-changing, innovative treatments for people with great needs, but few options. Join us in extending a warm welcome to Kyle on his first day as CEO!?
-
-
Today is World Mental Health Day, a time to raise awareness of mental health issues around the world and to mobilize efforts in support of mental health. The day provides an opportunity for all stakeholders working on mental health issues to talk about their work and what more needs to be done to make mental health care a reality for people worldwide. #MentalIllnessAwarenessWeek
-
-
Physician assistants are licensed clinicians who practice medicine in every specialty and setting. Trusted, rigorously educated and trained healthcare professionals, PAs are dedicated to expanding access to care and transforming health and wellness through patient-centered, team-based medical practice. This Physician Assistant Week, we honor their contributions to patient care. #PAweek #PAsGoBeyond
-